EUROPEAN SCHOOL OF HAEMATOLOGY (ESH) UPCOMING CONFERENCES 2018
ESH is pleased to announce that following upcoming conferences below:
Also, please click here for a link to the ESH programme
Clinical Updates on CLL and Indolent Lymphoma
2-4 March 2018, Paris, France
Chairs: Christian Buske, Catherine Wu and Pier Luigi Zinzani
4th International Conference on Hematologic Malignancies at Older age: Biology and Therapy
9-11 March 2018, Mandelieu, France
Chairs: Bob Löwenberg, Benjamin Ebert, Pierre Fenaux, Michael Halle
4th International Conference on New Concepts in Lymphoid Malignancies: Focus on Aggressive Lymphoma
28-30 September 2018, Saggart (Dublin), Ireland
Chairs: Georg Lenz, Franck Morschhauser, Laurie Sehn
ARTICLE ON THE ELN IN CANCER 2018
We are happy to inform you that the following article entitled “Advancing a Field by building consortia: The example of the European LeukemiaNet” appears in Cancer.
To read the article, please click here
REPRODUCIBLE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA BY FLOW CYTOMETRY: AN EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC) & EUROPEAN SOCIETY FOR CLINICAL CELL ANALYSIS (ESCCA) HARMONISATION PROJECT
We are pleased to announce that this article has now been published in an issue of the journal on Wiley Online Library.
Reproducible Diagnosis of Chronic Lymphocytic Leukemia by Flow Cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation Project. Cytometry Part B 2018; 94B: 121–128.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and
FORUM FOR THE DEVELOPMENT OF CLINICAL DIAGNOSTIC ASSAYS
On 29 January 2018, a one day meeting was held at the Villa Malpensa Hotel (Milan). The meeting provided an informal platform for interaction between academic
scientists/clinicians, biotechnology and pharmaceutical companies and regulatory bodies.
The aim of the meeting is to facilitate future assay development by:
– providing an opportunity to understand the challenges in developing clinically relevant assays
from the different viewpoints of laboratory, industry and regulator.
– identifying areas of development that would benefit from closer collaboration between different sectors
To view the agenda, please click here
EHA SCIENTIFIC WORKING GROUP
ERIC is pleased to announce that the Scientific Working Group (SWG) ERIC has been granted the official status of EHA Scientific Working Group for a period of 3 years (2018 – 2020).
CALL FOR LOIs – 2018/2019 Hairy Cell Leukemia Fellowship Awards
Letters of Intent for the 2018/2019 Hairy Cell Leukemia Fellowship Awards are now being accepted
The Fellowships are a collaboration of the Sass Foundation for Medical Research (SFMR) and the Hairy Cell Leukemia Foundation (HCLF) to fund effective research into the pathogenesis and treatment of hairy cell leukemia and to encourage investigators to pursue careers in the field of hairy cell leukemia research.
Fellowships are awarded for up to $75,000 per year for three (3) years
Eligibility and Guidelines
* Fellowship awards are aimed at investigators who wish to pursue a career involving clinical or
fundamental research in hairy cell leukemia or related leukemia research fields under an experienced research sponsor’s mentorship.
* The investigator should be engaged in academic medicine as an exceptional senior post-doctoral fellow (in the 3rd or 4th year of fellowship) or as a junior member of the faculty (within 3 years of completing a post-doctoral fellowship).
The full eligibility guidelines and application instructions are described in the attachment. Please click here to download it.
RECURRENT MUTATIONS REFINE PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA
We are pleased to inform you that “Recurrent mutations refine prognosis in chronic lymphocytic leukemia” was recently announced as one of Leukemia’s most highly cited papers from 2015.
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 2015 Feb;29(2):329-36. doi: 10.1038/leu.2014.196. Epub 2014 Jun 19.
Baliakas P, Hadzidimitriou A, Sutton LA, Rossi D, Minga E, Villamor N, Larrayoz M, Kminkova J, Agathangelidis A, Davis Z, Tausch E, Stalika E, Kantorova B, Mansouri L, Scarfò L, Cortese D, Navrkalova V, Rose-Zerilli MJ, Smedby KE, Juliusson G, Anagnostopoulos A, Makris AM, Navarro A, Delgado J, Oscier D, Belessi C, Stilgenbauer S, Ghia P, Pospisilova S, Gaidano G, Campo E, Strefford JC, Stamatopoulos K, Rosenquist R; European Research Initiative on CLL (ERIC).